| Calendar of Event|
Event Title: Learning and Neuroplasticity as Therapeutic Targets in Schizophrenia
| Date: 3/26/2010
Time: 11:00am -- 12:30pm|
|Place: New York State Psychiatric Institute - 1051 Riverside Drive - 1st Flr Auditorium - NYC 10032|
Speaker: Donald Goff, MD
Professor of Psychiatry, Harvard Medical School
Director, Schizophrenia Program
Massachusetts General Hospital
Host: L. Fredrik Jarskog, M.D.
Description: *ADULT PSYCHIATRY GRAND ROUNDS*
Dr. Donald Goff is Director of the Schizophrenia Program at Massachusetts General Hospital and Professor of Psychiatry at Harvard Medical School. Prior to his positions with the Massachusetts General Hospital and Harvard Medical School, Dr. Goff was Assistant Professor of Psychiatry at Tufts School of Medicine.
Dr. Goff earned his undergraduate degree in humanities at the University of California in Berkeley, and his medical degree at the University Of California School Of Medicine in Los Angeles. After graduating, he completed his internship in internal medicine at Cedars Sinai Medical Center in Los Angeles, and his residency in psychiatry at Massachusetts General Hospital in Boston. His research fellowship in psychopharmacology was completed at Tufts-New England Medical Center, also in Boston.
Dr. Goff has authored and co-authored over 200 articles concerning schizophrenia and related topics. He is Director of a clinical research program of 16 investigators integrating pharmacology, cognitive behavioral therapy, neuroimaging and genetics to enhance our understanding of the pathophysiology of schizophrenia and to develop new treatments. He also has been principal investigator for many studies concerning the treatment and management of schizophrenia.
Dr. Goff is a recipient of the Faculty Scholar Award in Schizophrenia, a Mid-Career Development Award presented by the National Institute of Mental Health; the Kempf Award for Mentorship in Biological Psychiatry from the American Psychiatric Association; the Wayne Fenton MD Award for Exceptional Clinical Care; and the Stanley Dean Award for Research in Schizophrenia from the American College of Psychiatrists. He is also a member of the American College of Neuropsychopharmacology.